There's still value in biotech stocks: Citi pro By: CNBC.com News April 07, 2014 at 18:23 PM EDT Despite the recent meltdown in biotechnology stocks, there are still areas of opportunity within the sector, Citi's Yaron Werber says. Read More >> Related Stocks: Biogen Idec Celgene Corp Gilead Sciences Regeneron Pharmaceuticals